The Inflation Reduction Act (IRA) is expected to profoundly influence the clinical development strategies of pharma companies ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

Swiss pharma group Novartis has said it will expand its US manufacturing and research and development with a $23bn investment over five years, as drugmakers reconfigure their supply chains as part of ...

Novo Nordisk and Sanofi were among companies threatening to hasten their exits to the U.S., as Trump promised pharma tariffs ...

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI ...

The New York Times reported that drugmakers are preparing for tariffs specifically targeting pharmaceuticals, with levies potentially hitting 25 percent or higher. Trump has repeatedly vowed to enact ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

No matter how high the inflation is, their demand is inelastic. No matter how slow the current profit growth is, these ...

Completed enrollment in the chronic cohort and commenced enrollment in the subacute cohort of its Phase 1b/2a clinical trial ...